These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20005475)

  • 21. Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
    Contractor H; Støttrup NB; Cunnington C; Manlhiot C; Diesch J; Ormerod JO; Jensen R; Bøtker HE; Redington A; Schmidt MR; Ashrafian H; Kharbanda RK
    Basic Res Cardiol; 2013 May; 108(3):343. PubMed ID: 23525499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection.
    Gong D; Zhang H; Hu S
    J Mol Cell Cardiol; 2013 Feb; 55():58-63. PubMed ID: 22507541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
    Pan G; Roy B; Palaniyandi SS
    J Am Heart Assoc; 2021 Sep; 10(18):e021140. PubMed ID: 34482710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance.
    Sun L; Ferreira JC; Mochly-Rosen D
    Sci Transl Med; 2011 Nov; 3(107):107ra111. PubMed ID: 22049071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote ischemic postconditioning alleviates myocardial ischemia/reperfusion injury by up-regulating ALDH2.
    Zhang ZX; Li H; He JS; Chu HJ; Zhang XT; Yin L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6475-6484. PubMed ID: 30338817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury.
    Liu B; Wang J; Li M; Yuan Q; Xue M; Xu F; Chen Y
    Oncotarget; 2017 Mar; 8(12):19413-19426. PubMed ID: 28038474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury.
    Ding J; Yang Z; Ma H; Zhang H
    Adv Exp Med Biol; 2019; 1193():107-120. PubMed ID: 31368100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophic preconditioning cardioprotection after myocardial ischaemia/reperfusion injury involves ALDH2-dependent metabolism modulation.
    Ma LL; Ding ZW; Yin PP; Wu J; Hu K; Sun AJ; Zou YZ; Ge JB
    Redox Biol; 2021 Jul; 43():101960. PubMed ID: 33910156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes.
    Fu SH; Zhang HF; Yang ZB; Li TB; Liu B; Lou Z; Ma QL; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):87-94. PubMed ID: 24081521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1.
    Beretta M; Gorren AC; Wenzl MV; Weis R; Russwurm M; Koesling D; Schmidt K; Mayer B
    J Biol Chem; 2010 Jan; 285(2):943-52. PubMed ID: 19906643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-apoptotic role of mitochondrial aldehyde dehydrogenase 2 in myocardial ischemia/reperfusion injury in diabetic rats].
    Wang HJ; Kang PF; Ye HW; Yu Y; Wang XM; Gao Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):345-8. PubMed ID: 22445980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.
    Song BJ; Abdelmegeed MA; Yoo SH; Kim BJ; Jo SA; Jo I; Moon KH
    J Proteomics; 2011 Nov; 74(12):2691-702. PubMed ID: 21609791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldehyde Dehydrogenase 2 Preserves Mitochondrial Function in the Ischemic Heart: A Redox-dependent Mechanism for AMPK Activation by Thioredoxin-1.
    Zhu Y; He YJ; Yu Y; Xu D; Yuan SY; Yan H
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):93-104. PubMed ID: 37816196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes.
    Li SP; Liu B; Song B; Wang CX; Zhou YC
    Eur Rev Med Pharmacol Sci; 2015; 19(5):752-8. PubMed ID: 25807426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury.
    Budas GR; Churchill EN; Disatnik MH; Sun L; Mochly-Rosen D
    Cardiovasc Res; 2010 Oct; 88(1):83-92. PubMed ID: 20558438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting ALDH2 for Therapeutic Interventions in Chronic Pain-Related Myocardial Ischemic Susceptibility.
    Li C; Sun W; Gu C; Yang Z; Quan N; Yang J; Shi Z; Yu L; Ma H
    Theranostics; 2018; 8(4):1027-1041. PubMed ID: 29463997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.
    Ebert AD; Kodo K; Liang P; Wu H; Huber BC; Riegler J; Churko J; Lee J; de Almeida P; Lan F; Diecke S; Burridge PW; Gold JD; Mochly-Rosen D; Wu JC
    Sci Transl Med; 2014 Sep; 6(255):255ra130. PubMed ID: 25253673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial aldehyde dehydrogenase and cardiac diseases.
    Chen CH; Sun L; Mochly-Rosen D
    Cardiovasc Res; 2010 Oct; 88(1):51-7. PubMed ID: 20558439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
    Koda K; Salazar-Rodriguez M; Corti F; Chan NY; Estephan R; Silver RB; Mochly-Rosen D; Levi R
    Circulation; 2010 Aug; 122(8):771-81. PubMed ID: 20697027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease.
    Zhang H; Gong DX; Zhang YJ; Li SJ; Hu S
    Eur Heart J; 2012 Jul; 33(13):1606-14. PubMed ID: 22507973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.